Balance Sheet Advanced Medical Solutions Group plc

Stocks

AMS

GB0004536594

Medical Equipment, Supplies & Distribution

Real-time Estimate Cboe Europe Other stock markets 11:45:10 22/07/2026 BST			5-day change	1st Jan Change
280.25 ^GBX	-0.09%		+0.18%	+28.44%

07-20	Advanced Medical Solutions expects first-half revenue growth	AN
07-20	Advanced Medical Solutions Group plc Provides Earnings Guidance for the Half Year 2026	CI

26156f93542d2681acfae7d.NsBJ7jaZww1VCR7NmqLHfrdYpOgz1724_Mip_J9Jjn0.XO1xnHHNs2VhRnCi_e2JPIcz6KJ_tfzttf3fi_Af5BAC8zO-W82TYDxoVw

Published financial data: ADVANCED MEDICAL SOLUTIONS GROUP PLC

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	109M	124M	126M	178M	229M
Total Revenues	109M	124M	126M	178M	229M
Cost of Goods Sold, Total	47.53M	50.91M	56.07M	84.9M	107M
Gross Profit	61.07M	73.42M	70.14M	92.62M	122M
Selling General & Admin Expenses, Total	38.45M	49M	52.19M	82.3M	100M
Other Operating Expenses	-381K	-478K	-931K	-906K	-671K
Other Operating Expenses, Total	38.07M	48.53M	51.26M	81.4M	99.48M
Operating Income	23M	24.89M	18.88M	11.22M	22.66M
Interest Expense, Total	-672K	-638K	-384K	-3.56M	-5.05M
Interest And Investment Income	84K	1.69M	2.47M	1.29M	211K
Net Interest Expenses	-588K	1.05M	2.09M	-2.26M	-4.84M
Other Non Operating Income (Expenses)	-426K	-33K	186K	868K	-42K
EBT, Excl. Unusual Items	21.98M	25.91M	21.16M	9.82M	17.78M
Merger & Related Restructuring Charges	-	-	-	-	-
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	21.98M	25.91M	21.16M	9.82M	17.78M
Income Tax Expense	4.5M	5.5M	5.27M	2.68M	7.69M
Earnings From Continuing Operations	17.48M	20.41M	15.89M	7.14M	10.1M
Net Income to Company	17.48M	20.41M	15.89M	7.14M	10.1M
Minority Interest	-	-	-	-48K	-141K
Net Income - (IS)	17.48M	20.41M	15.89M	7.09M	9.95M
Net Income to Common Incl Extra Items	17.48M	20.41M	15.89M	7.09M	9.95M
Net Income to Common Excl. Extra Items	17.48M	20.41M	15.89M	7.09M	9.95M
Per Share Items
Net EPS - Basic	0.08	0.09	0.07	0.03	0.05
Basic EPS - Continuing Operations	0.08	0.09	0.07	0.03	0.05
Basic Weighted Average Shares Outstanding	216M	217M	216M	214M	216M
Net EPS - Diluted	0.08	0.09	0.07	0.03	0.05
Diluted EPS - Continuing Operations	0.08	0.09	0.07	0.03	0.05
Diluted Weighted Average Shares Outstanding	218M	219M	219M	218M	220M
Normalized Basic EPS	0.06	0.07	0.06	0.03	0.05
Normalized Diluted EPS	0.06	0.07	0.06	0.03	0.05
Dividend Per Share	0.02	0.02	0.02	0.03	0.03
Payout Ratio	22	21.27	30.05	73.32	58.18
Supplemental Items
EBITDA	28.67M	30.94M	26.6M	22.7M	37.04M
EBITA	26.18M	28.3M	23.77M	19.02M	32.98M
EBIT	23M	24.89M	18.88M	11.22M	22.66M
EBITDAR	-	-	-	-	-
Effective Tax Rate - (Ratio)	20.48	21.24	24.9	27.29	43.23
Total Current Taxes	4.61M	5.66M	4.98M	5.18M	6.45M
Total Deferred Taxes	-110K	-157K	292K	-2.5M	1.24M
Normalized Net Income	13.74M	16.19M	13.22M	6.09M	10.97M
Interest on Long-Term Debt	651K	599K	364K	463K	617K
Supplemental Operating Expense Items
Selling and Marketing Expenses	1.48M	1.63M	1.52M	2.35M	3.85M
General and Administrative Expenses	36.97M	47.38M	50.67M	79.96M	96.3M
Research And Development Expense From Footnotes	5.09M	5.2M	6.6M	7.25M	7.5M
Net Rental Expense, Total	-	-	-	-	-
Stock-Based Comp., Other (Total)	1.98M	2.44M	2.92M	3.09M	4.14M
Total Stock-Based Compensation	1.98M	2.44M	2.92M	3.09M	4.14M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	72.96M	82.26M	60.16M	17.04M	18.02M
Total Cash And Short Term Investments	72.96M	82.26M	60.16M	17.04M	18.02M
Accounts Receivable, Total	17.52M	17.71M	20.91M	45.91M	38.46M
Other Receivables	3.38M	2.68M	1.77M	5.66M	8M
Total Receivables	20.9M	20.39M	22.68M	51.57M	46.46M
Inventory	19.3M	27.91M	36.05M	55.26M	70.05M
Prepaid Expenses	1.81M	1.34M	1.29M	2.12M	3.63M
Other Current Assets, Total	-	-	2.14M	296K	1.21M
Total Current Assets	115M	132M	122M	126M	139M
Gross Property Plant And Equipment	55.65M	60.28M	64.27M	86.28M	95.43M
Accumulated Depreciation	-28.21M	-31.26M	-34.67M	-40.41M	-46.68M
Net Property Plant And Equipment	27.44M	29.02M	29.6M	45.87M	48.75M
Goodwill	66.03M	70.86M	80.44M	117M	113M
Other Intangibles, Total	30.48M	32.51M	34.88M	70.64M	63.36M
Accounts Receivable Long-Term	-	-	-	-	-
Deferred Tax Assets Long-Term	-	-	356K	1.02M	-
Deferred Charges Long-Term	10.48M	15.86M	20.99M	26.78M	29.37M
Other Long-Term Assets, Total	105K	937K	593K	1.03M	1.23M
Total Assets	250M	281M	289M	388M	395M
Liabilities
Accounts Payable, Total	4.88M	6.42M	6.23M	13.86M	13.26M
Accrued Expenses, Total	6.41M	6.71M	3.92M	8.93M	10.44M
Current Portion of Long-Term Debt	-	-	-	5.42M	11.37M
Current Portion of Leases	1.15M	1.06M	1.16M	3.09M	3.33M
Current Income Taxes Payable	897K	948K	1.16M	1.78M	4.29M
Other Current Liabilities	3.67M	7.54M	9.11M	11.25M	7.25M
Total Current Liabilities	17.01M	22.68M	21.58M	44.33M	49.95M
Long-Term Debt	-	-	-	67.43M	57.1M
Long-Term Leases	8.71M	8.69M	7.97M	10.63M	9.72M
Deferred Tax Liability Non Current	7.44M	9.59M	11.01M	20.25M	13.08M
Other Non Current Liabilities	3.68M	3.51M	4.4M	4.35M	4.81M
Total Liabilities	36.83M	44.47M	44.97M	147M	135M
Common Stock, Total	10.8M	10.84M	10.86M	10.89M	10.98M
Additional Paid In Capital	38.53M	38.8M	39M	37.52M	37.84M
Retained Earnings	151M	167M	179M	180M	185M
Treasury Stock	-164K	-167K	-6.88M	-	-
Comprehensive Income and Other	12.16M	19.73M	22.68M	11.89M	25.33M
Total Common Equity	213M	237M	244M	241M	259M
Minority Interest	-	-	-	739K	1.31M
Total Equity	213M	237M	244M	242M	260M
Total Liabilities And Equity	250M	281M	289M	388M	395M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	216M	217M	214M	214M	216M
ECS Total Common Shares Outstanding	216M	217M	214M	214M	216M
Book Value / Share	0.99	1.09	1.14	1.12	1.2
Tangible Book Value	116M	133M	129M	53.26M	82.73M
Tangible Book Value Per Share	0.54	0.61	0.6	0.25	0.38
Total Debt	9.86M	9.75M	9.14M	86.56M	81.52M
Net Debt	-63.1M	-72.51M	-51.02M	69.52M	63.51M
Debt Equivalent Oper. Leases	-	-	-	-	-
Minority Interest, Total (Incl. Fin. Div)	-	-	-	739K	1.31M
Account Code - Inventory Valuation	3	3	3	3	3
Inventories - Raw Materials, Total	7.86M	11.54M	13.24M	19.69M	25.67M
Inventories - Work In Process, Total	4.97M	6.77M	7.8M	9.62M	11.31M
Inventories - Finished Goods, Total	6.47M	9.6M	15.01M	25.95M	33.07M
Land - (BS)	5.82M	7.35M	7.52M	15.14M	17.92M
Machinery, Total	35.16M	37.63M	41.35M	48.78M	52.98M
Full Time Employees	700	800	850	1.6K	1.8K
Accumulated Allowance for Doubtful Accounts (Supple)	225K	275K	360K	445K	863K

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	17.48M	20.41M	15.89M	7.09M	9.95M
Depreciation & Amortization - CF	3.89M	4.05M	4.38M	6.45M	8.04M
Amortization of Goodwill and Intangible Assets - (CF)	3.18M	3.41M	4.89M	7.8M	10.31M
Depreciation & Amortization, Total	7.07M	7.46M	9.26M	14.26M	18.35M
Amortization of Deferred Charges, Total - (CF)	1.78M	1.38M	1.53M	2.04M	3.05M
Asset Writedown & Restructuring Costs	-	-	-	-	-
Stock-Based Compensation (CF)	1.98M	2.44M	2.92M	3.09M	4.14M
Other Operating Activities, Total	1.44M	1.16M	-1.42M	-925K	7.38M
Change In Accounts Receivable	-1.77M	-596K	-2.52M	-10.38M	5.04M
Change In Inventories	941K	-7.09M	-8.06M	-2K	-13.27M
Change In Accounts Payable	2.1M	1.71M	-5.25M	4.32M	-2.05M
Cash from Operations	31.02M	26.88M	12.34M	19.49M	32.59M
Capital Expenditure	-1.77M	-3.74M	-3.54M	-4.06M	-7.36M
Sale of Property, Plant, and Equipment	53K	46K	42K	27K	54K
Cash Acquisitions	-	-2.78M	-5.53M	-54.13M	72K
Sale (Purchase) of Intangible assets	-4.7M	-6.22M	-6.3M	-4.69M	-5.24M
Other Investing Activities, Total	84K	820K	-4.93M	-4.3M	-857K
Cash from Investing	-6.33M	-11.88M	-20.26M	-67.15M	-13.33M
Long-Term Debt Issued, Total	-	-	-	79.45M	-
Total Debt Issued	-	-	-	79.45M	-
Short Term Debt Repaid, Total	-	-	-	-	-576K
Long-Term Debt Repaid, Total	-1.28M	-1.63M	-1.95M	-64.8M	-8.88M
Total Debt Repaid	-1.28M	-1.63M	-1.95M	-64.8M	-9.46M
Issuance of Common Stock	1.09M	655K	181K	12K	329K
Repurchase of Common Stock	-366K	-392K	-6.71M	-	-
Common Dividends Paid	-3.84M	-4.34M	-4.78M	-5.2M	-5.79M
Common & Preferred Stock Dividends Paid	-3.84M	-4.34M	-4.78M	-5.2M	-5.79M
Other Financing Activities, Total	-700K	-617K	-362K	-3.99M	-4.04M
Cash from Financing	-5.1M	-6.32M	-13.62M	5.48M	-18.97M
Foreign Exchange Rate Adjustments	-458K	620K	-564K	-939K	688K
Net Change in Cash	19.14M	9.3M	-22.1M	-43.12M	976K
Supplemental Items
Cash Interest Paid	700K	617K	362K	3.99M	4.04M
Cash Income Tax Paid (Refund)	4.08M	3.32M	4.41M	5.05M	5.33M
Levered Free Cash Flow	22.05M	14.6M	1.7M	-16.24M	11.26M
Unlevered Free Cash Flow	22.47M	15M	1.94M	-14.02M	14.41M
Change In Net Working Capital	-3.74M	1.88M	13.71M	31.67M	12.69M
Net Debt Issued / Repaid	-1.28M	-1.63M	-1.95M	14.66M	-9.46M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5.89	5.86	4.14	2.07	3.62
Return on Total Capital	6.6	6.64	4.72	2.41	4.23
Return On Equity %	8.43	9.08	6.61	2.94	4.02
Return on Common Equity	8.43	9.08	6.61	2.93	3.98
Margin Analysis
Gross Profit Margin %	56.23	59.05	55.57	52.17	53.35
SG&A Margin	35.41	39.41	41.35	46.36	43.74
EBITDA Margin %	26.4	24.89	21.07	12.79	16.18
EBITA Margin %	24.1	22.77	18.83	10.72	14.4
EBIT Margin %	21.18	20.02	14.96	6.32	9.9
Income From Continuing Operations Margin %	16.1	16.41	12.59	4.02	4.41
Net Income Margin %	16.1	16.41	12.59	4	4.35
Net Avail. For Common Margin %	16.1	16.41	12.59	4	4.35
Normalized Net Income Margin	12.65	13.02	10.48	3.43	4.79
Levered Free Cash Flow Margin	20.31	11.74	1.35	-9.15	4.92
Unlevered Free Cash Flow Margin	20.69	12.06	1.54	-7.9	6.29
Asset Turnover
Asset Turnover	0.45	0.47	0.44	0.52	0.58
Fixed Assets Turnover	3.78	4.4	4.31	4.7	4.84
Receivables Turnover (Average Receivables)	6.17	7.06	6.54	5.31	5.43
Inventory Turnover (Average Inventory)	2.36	2.16	1.75	1.86	1.7
Short Term Liquidity
Current Ratio	6.76	5.82	5.67	2.85	2.79
Quick Ratio	5.52	4.53	3.84	1.55	1.29
Operating Cash Flow to Current Liabilities	1.82	1.19	0.57	0.44	0.65
Days Sales Outstanding (Average Receivables)	59.12	51.7	55.84	68.88	67.25
Days Outstanding Inventory (Average Inventory)	154.83	169.23	208.17	196.8	214.13
Average Days Payable Outstanding	46.49	34.63	35.94	35.3	40.71
Cash Conversion Cycle (Average Days)	167.46	186.3	228.07	230.38	240.67
Long Term Solvency
Total Debt/Equity	4.64	4.12	3.74	35.84	31.34
Total Debt / Total Capital	4.43	3.96	3.61	26.38	23.86
LT Debt/Equity	4.09	3.67	3.26	32.32	25.69
Long-Term Debt / Total Capital	3.91	3.53	3.15	23.79	19.56
Total Liabilities / Total Assets	14.76	15.82	15.55	37.83	34.11
EBIT / Interest Expense	34.22	39.01	49.17	3.15	4.49
EBITDA / Interest Expense	44.75	50.71	73.29	7.16	8.12
(EBITDA - Capex) / Interest Expense	42.12	44.85	64.06	6.02	6.67
Total Debt / EBITDA	0.33	0.3	0.32	3.4	1.99
Net Debt / EBITDA	-2.1	-2.24	-1.81	2.73	1.55
Total Debt / (EBITDA - Capex)	0.35	0.34	0.37	4.04	2.42
Net Debt / (EBITDA - Capex)	-2.23	-2.53	-2.07	3.25	1.89
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	25.12	14.48	1.51	40.66	28.96
Gross Profit, 1 Yr. Growth %	32.65	20.22	-4.46	32.05	31.87
EBITDA, 1 Yr. Growth %	78.79	7.93	-14.04	-14.65	63.19
EBITA, 1 Yr. Growth %	89.24	8.13	-16.02	-19.97	73.34
EBIT, 1 Yr. Growth %	98.88	8.23	-24.14	-40.58	102
Earnings From Cont. Operations, 1 Yr. Growth %	103.65	16.73	-22.14	-55.05	41.35
Net Income, 1 Yr. Growth %	103.65	16.73	-22.14	-55.35	40.32
Normalized Net Income, 1 Yr. Growth %	101.26	17.86	-18.34	-53.93	80.15
Diluted EPS Before Extra, 1 Yr. Growth %	103.3	16.11	-22.04	-55.17	39.08
Accounts Receivable, 1 Yr. Growth %	-0.84	1.11	18.06	119.56	-16.23
Inventory, 1 Yr. Growth %	-8.2	44.62	29.15	53.3	26.76
Net Property, Plant and Equip., 1 Yr. Growth %	-8.72	5.74	2.02	54.96	6.28
Total Assets, 1 Yr. Growth %	4.59	12.66	2.87	34.35	1.61
Tangible Book Value, 1 Yr. Growth %	17.78	14.71	-3.27	-58.68	55.34
Common Equity, 1 Yr. Growth %	5.18	11.26	3.2	-1.4	7.48
Cash From Operations, 1 Yr. Growth %	44.23	-13.37	-54.07	57.87	67.21
Capital Expenditures, 1 Yr. Growth %	-24.64	111.48	-5.22	14.48	81.37
Levered Free Cash Flow, 1 Yr. Growth %	95.68	-33.79	-88.34	-1.05K	-169.31
Unlevered Free Cash Flow, 1 Yr. Growth %	92.02	-33.26	-87.05	-821.7	-202.81
Dividend Per Share, 1 Yr. Growth %	14.71	10.26	9.77	10.17	10
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	3	19.68	7.8	19.49	34.68
Gross Profit, 2 Yr. CAGR %	0.48	26.28	7.17	12.32	31.96
EBITDA, 2 Yr. CAGR %	-0.69	38.91	-3.68	-14.35	18.02
EBITA, 2 Yr. CAGR %	-1.5	43.04	-4.71	-18.02	17.78
EBIT, 2 Yr. CAGR %	-4.65	46.71	-9.39	-32.86	9.55
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.88	54.18	-4.66	-40.84	-20.29
Net Income, 2 Yr. CAGR %	-3.88	54.18	-4.66	-41.04	-20.85
Normalized Net Income, 2 Yr. CAGR %	-6.8	54.01	-1.9	-38.67	-8.9
Diluted EPS Before Extra, 2 Yr. CAGR %	-4.16	53.64	-4.86	-40.88	-21.04
Accounts Receivable, 2 Yr. CAGR %	-17.33	0.13	9.26	61	35.62
Inventory, 2 Yr. CAGR %	4.56	15.22	36.66	40.71	39.4
Net Property, Plant and Equip., 2 Yr. CAGR %	-0.48	-1.76	3.86	25.74	28.33
Total Assets, 2 Yr. CAGR %	4.84	8.55	7.66	17.56	16.84
Tangible Book Value, 2 Yr. CAGR %	3.05	16.23	5.34	-36.78	-19.88
Common Equity, 2 Yr. CAGR %	5.46	8.17	7.16	0.87	2.94
Cash From Operations, 2 Yr. CAGR %	19.57	11.78	-36.92	-14.85	62.47
Capital Expenditures, 2 Yr. CAGR %	-18.67	26.24	41.58	4.17	44.09
Levered Free Cash Flow, 2 Yr. CAGR %	46.34	13.82	-72.22	5.47	157.14
Unlevered Free Cash Flow, 2 Yr. CAGR %	44.53	13.21	-70.6	-3.33	172.39
Dividend Per Share, 2 Yr. CAGR %	12.16	12.46	10.01	9.97	10.08
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.91	6.69	13.29	17.8	22.57
Gross Profit, 3 Yr. CAGR %	-1.24	6.67	15.06	14.89	18.49
EBITDA, 3 Yr. CAGR %	-2.7	2.11	18.37	-7.48	6.18
EBITA, 3 Yr. CAGR %	-3.31	1.61	19.77	-10.09	5.22
EBIT, 3 Yr. CAGR %	-7.31	-0.54	17.76	-21.28	-3.08
Earnings From Cont. Operations, 3 Yr. CAGR %	-8.05	2.55	22.78	-25.8	-20.91
Net Income, 3 Yr. CAGR %	-8.05	2.55	22.78	-25.96	-21.28
Normalized Net Income, 3 Yr. CAGR %	-8.47	0.78	24.65	-23.75	-12.17
Diluted EPS Before Extra, 3 Yr. CAGR %	-8.37	2.17	22.54	-25.97	-21.38
Accounts Receivable, 3 Yr. CAGR %	-10.78	-11.59	5.78	37.88	29.5
Inventory, 3 Yr. CAGR %	9.25	16.49	19.69	42	35.9
Net Property, Plant and Equip., 3 Yr. CAGR %	-0.49	1.55	-0.52	18.68	18.88
Total Assets, 3 Yr. CAGR %	6.73	7.39	6.62	15.9	11.99
Tangible Book Value, 3 Yr. CAGR %	-0.62	6.8	9.33	-22.89	-14.69
Common Equity, 3 Yr. CAGR %	7.18	7.36	6.49	4.22	3.03
Cash From Operations, 3 Yr. CAGR %	12.7	7.39	-16.9	-14.36	6.63
Capital Expenditures, 3 Yr. CAGR %	-16.73	11.84	14.74	31.9	25.31
Levered Free Cash Flow, 3 Yr. CAGR %	17.18	12.34	-46.74	-9.7	-8.31
Unlevered Free Cash Flow, 3 Yr. CAGR %	16.9	11.72	-45.05	-14.56	-1.33
Dividend Per Share, 3 Yr. CAGR %	13.89	11.52	11.55	10.06	9.98
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	5.46	5.11	4.23	11.64	21.41
Gross Profit, 5 Yr. CAGR %	4.91	4.68	2.04	8.9	21.55
EBITDA, 5 Yr. CAGR %	5.82	2.44	-3.09	-4.82	18.23
EBITA, 5 Yr. CAGR %	5.84	2.21	-3.87	-6.75	18.97
EBIT, 5 Yr. CAGR %	3.39	-0.28	-8.15	-15.01	14.4
Earnings From Cont. Operations, 5 Yr. CAGR %	2.18	0.27	-6.71	-17.7	3.3
Net Income, 5 Yr. CAGR %	2.18	0.27	-6.71	-17.81	3.01
Normalized Net Income, 5 Yr. CAGR %	2.47	0.5	-5.9	-17.38	9.96
Diluted EPS Before Extra, 5 Yr. CAGR %	1.65	-0.19	-6.98	-17.91	2.79
Accounts Receivable, 5 Yr. CAGR %	10.87	-1.44	-3.25	12.37	16.84
Inventory, 5 Yr. CAGR %	11.03	20.31	19.49	25.63	27.21
Net Property, Plant and Equip., 5 Yr. CAGR %	11.15	11.26	1.23	10.61	10.15
Total Assets, 5 Yr. CAGR %	11.47	10.75	7.1	11.35	10.6
Tangible Book Value, 5 Yr. CAGR %	9.67	6.36	1.72	-13.41	-3.45
Common Equity, 5 Yr. CAGR %	11.12	9.19	7.17	4.72	5.06
Cash From Operations, 5 Yr. CAGR %	9.37	9.64	-10.65	-2.13	8.66
Capital Expenditures, 5 Yr. CAGR %	3.03	5.21	2.97	8.7	25.69
Levered Free Cash Flow, 5 Yr. CAGR %	8.73	24.88	-34.11	9.54	-0.02
Unlevered Free Cash Flow, 5 Yr. CAGR %	9.14	25.56	-32.7	5.44	4.25
Dividend Per Share, 5 Yr. CAGR %	16.21	14.34	12.32	10.9	10.96